Lombard, IL, United States of America

Shrikant V Kulkarni

This inventor holds 1 USPTO granted patent. Top assignee: Strategic Medical Research Corporation. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shrikant V Kulkarni. Retrieved from https://idiyas.com/inventor/shrikant-v-kulkarni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shrikant V Kulkarni: Innovator in Monosaccharide Derivatives

Introduction: Shrikant V Kulkarni is a notable inventor based in Lombard, IL (US), recognized for his contributions to the field of chemistry, particularly in the preparation of ethers of monosaccharides. His innovative methods have significant implications in therapeutic applications.

Latest Patents: Kulkarni holds a patent for the "Preparation of ethers of monosaccharides." This patent details a method for creating ethereally substituted monosaccharides from selectively derivatized monosaccharides, showcasing his expertise in organic chemistry.

Career Highlights: Kulkarni's career is marked by his work at Strategic Medical Research Corporation, where he has applied his knowledge to develop compounds with antiviral activity and other therapeutic properties. His method allows for high yield and purity of the resultant compounds, minimizing side products.

Collaborations: Throughout his career, Kulkarni has collaborated with esteemed colleagues such as Paul Gordon and Bruce Ronsen. These partnerships have contributed to the advancement of research in his field.

Conclusion: Shrikant V Kulkarni's innovative work in the preparation of monosaccharide derivatives highlights his significant role in the scientific community. His contributions continue to influence therapeutic research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…